Thromb Haemost 1995; 73(04): 735-736
DOI: 10.1055/s-0038-1653857
Letters to the Editor
Schattauer GmbH Stuttgart

Continuous Infusion of Prostacyclin Decreases Plasma Levels of t-PA and PAI-1 in Primary Pulmonary Hypertension

C Boyer-Neumann
1   The Laboratoire d’Hématologie, Paris, France
,
F Brenot
2   The Service de Pneumologie, Hôpital Antoine Béclère, Clamart, Paris, France
,
M Wolf
1   The Laboratoire d’Hématologie, Paris, France
,
E Peynaud-Debayle
1   The Laboratoire d’Hématologie, Paris, France
,
P Duroux
2   The Service de Pneumologie, Hôpital Antoine Béclère, Clamart, Paris, France
,
D Meyer
1   The Laboratoire d’Hématologie, Paris, France
3   Inserm U.143, Hôpital de Bicêtre, Paris, France
,
E Anglés-Cano
3   Inserm U.143, Hôpital de Bicêtre, Paris, France
,
G Simonneau
2   The Service de Pneumologie, Hôpital Antoine Béclère, Clamart, Paris, France
› Author Affiliations
Further Information

Publication History

Received 30 August 1994

Accepted after resubmission 22 December 1994

Publication Date:
09 July 2018 (online)

 
  • References

  • 1 Rubin LJ. Primary pulmonary hypertension. Chest 1993; 104: 236-250
  • 2 Anglés-Cano E, Sultan Y, Clauvel J-P. Predisposing factors to thrombosis in systemic lupus erythematosus. Possible relation to endothelial cell damage J Lab Clin Med 1979; 94: 312-323
  • 3 Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327: 70-75
  • 4 Higenbottam TW, Spiegelhalter D, Scott J-P, Fuster V, Dinh-Xuan AT, Caine N, Wallwork J. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J 1993; 70: 366-370
  • 5 Anglés-Cano E, Grailhe P, Boyer-Neumann C, Brenot F, Peynaud-Debayle E, Azarian R, Simonneau G, Duroux P, Meyer D. Markers of endothelial involvement in chronic pulmonary hypertension. Fibrinolysis 1994; 8 suppl (Suppl. 01) 139 Abstr